Cargando…
Antidiabetic Agents for Treatment of Parkinson’s Disease: A Meta-Analysis
Background: Clinical and epidemiological studies suggest that two of the most common geriatric diseases, type 2 diabetes and Parkinson’s disease (PD), are linked. These studies notably suggest that treatment of insulin resistance in type 2 diabetes may beneficially modify the pathophysiology of PD a...
Autores principales: | Wang, Shu-Yi, Wu, Shey-Lin, Chen, Ta-Cheng, Chuang, Chieh-Sen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369739/ https://www.ncbi.nlm.nih.gov/pubmed/32635358 http://dx.doi.org/10.3390/ijerph17134805 |
Ejemplares similares
-
Association between β2-Adrenoreceptor Medications and Risk of Parkinson’s Disease: A Meta-Analysis
por: Chen, Chu-Ling, et al.
Publicado: (2021) -
Role of antidiabetic agents in type 2 diabetes patients with chronic kidney disease
por: Lin, Wei-Ren, et al.
Publicado: (2023) -
Two Birds One Stone: The Neuroprotective Effect of Antidiabetic Agents on Parkinson Disease—Focus on Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors
por: Lin, Kai-Jung, et al.
Publicado: (2021) -
Exploring the Potential of Antidiabetic Agents as Therapeutic Approaches for Alzheimer's and Parkinson's Diseases: A Comprehensive Review
por: Koshatwar, Mahima, et al.
Publicado: (2023) -
Discovery of Akt Kinase Inhibitors through Structure-Based Virtual Screening and Their Evaluation as Potential Anticancer Agents
por: Chuang, Chih-Hung, et al.
Publicado: (2015)